AI is changing how HCPs identify patients, make decisions, and choose treatments. This exclusive event, hosted in collaboration with HLTH and Viz.ai, will convene senior life sciences leaders, clinical experts, and health system executives to examine what happens when AI becomes part of routine care, and what that requires of pharma commercial, medical, and brand teams.
Nearly three quarters of US physicians now use AI in practice, up from under 40% in 2023. AI-powered clinical tools are helping HCPs find the right patients earlier, reach the right diagnosis faster, and move them to the appropriate specialist or treatment pathway with greater adherence to guidelines. These tools sit inside the workflow, at the moment decisions are made.
We will look at the specific workflows where this is playing out, and what factors impact whether HCPs adopt an AI tool.
The agenda will include:
Expert HCP Panel: HCP leaders share real-world perspectives on how they’re using AI today and its influence on patient identification, treatment decisions, and guideline adherence
Pharma Executive Panel: Senior pharma leaders share what AI-driven clinical decision support and care coordination mean for commercial strategy and the future of HCP engagement.
Roundtable Discussions: Guided small-group conversations on HCP trust in AI, where workflow AI fits in the commercial plan, and what early adopters are seeing
Optional Networking Reception: Continue the conversation with peers and speakers.











